Abstract:Currently worldwide attention has focused on the derivation of human embryonic stem cells (hESCs) for future therapeutic medicine. However, the majority of existing hESCs are directly or indirectly exposed to non-human materials during their derivation and/or propagation, which greatly restrict their therapeutic potential. Besides the efforts to improve culture systems, the derivation procedure, especially blastocyst manipulation, needs to be optimized. We adopted a non-contact laser-assisted hatching system in combination with sequential culture process to obtain hatched blastocysts as materials for hESC derivation, and derived a hESC line ZJUhES-1 of a Chinese population without exposure to any non-human materials during blastocyst manipulation. ZJUhES-1 satisfies the criteria of pluripotent hESCs: typically morphological characteristics; the expression of alkaline phosphatase, human telomerase reverse transcriptase and multiple hESC-specific markers including SSEA-3, SSEA-4, TRA-1-60, TRA-1-81, OCT-4, Nanog, Rex-1, Sox-2, UTF-1, Connexins 43 and 45, TERF-1 and TERF-2, Glut-1, BCRP-1/ABCG-2, GDF3, LIN28, FGF4, Thy-1, Cripto1/TDGF1, AC133 as well as SMAD1/2/3/5; extended proliferative capacity; maintenance of a stable male karyotype after long-term cultivation; and robust multiple-lineage developmental potentials both in vivo and in vitro. Moreover, ZJUhES-1 has distinct identity revealed from DNA fingerprinting. Our xeno-free blastocyst manipulation procedure may promote the progression toward clinical-grade hESC derivation.

Requirements for human embryonic stem cells

Requirements for human‐induced pluripotent stem cells

General requirements for stem cells

Requirements for human haematopoietic stem/progenitor cells

Requirements for human cardiomyocytes

Technical Specifications for Ethics Review of Human Stem Cell Research

General requirements for the production of extracellular vesicles derived from human stem cells

Requirments for primary human hepatocyte

Accreditation of Biosafe Clinical-Grade Human Embryonic Stem Cells According to Chinese Regulations

Derivation, Characterization and Differentiation of a New Human Embryonic Stem Cell Line from a Chinese Hatched Blastocyst Assisted by a Non-Contact Laser System

[Progress in the Derivation, Culture of Human Embryonic Stem Cells].

Requirements for human pluripotent stem cell derived small extracellular vesicles

The ISSCR Guidelines for Human Embryonic Stem Cell Research

Ethical Management of Study on Human Embryonic Stem Cells Isolation

Human Embryo Research, Stem Cell-Derived Embryo Models and in Vitro Gametogenesis: Considerations Leading to the Revised ISSCR Guidelines.

Ethics: China already has clear stem-cell guidelines

Human midbrain dopaminergic progenitors

Ethical regulation and supervision of clinical stem cell research and application

[Current State of Establishing and Maintaining Human Embryonic Stem Cell Lines and Key Problems in These Studies].

[Development of Human Embryonic Stem Cell Platforms for Human Health-Safety Evaluation].

[Development of Human Embryonic Stem Cell Model for Toxicity Evaluation].